InvestorsHub Logo
Followers 65
Posts 23724
Boards Moderated 0
Alias Born 11/23/2016

Re: None

Monday, 12/10/2018 8:35:50 AM

Monday, December 10, 2018 8:35:50 AM

Post# of 457673
Another Anavex CNS competitor reliably flunks again!

“Axovant's nelotanserin flunks mid-stage study, shares down 27% premarket”
https://seekingalpha.com/news/3415568
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News